Alternative TAVR access approaches, courtesy of Interventional Cardiology Review 2018;13(3):145–50.
Researchers examined data from eight different studies, noting that transcaval TAVR appears to be a "viable alternative" when transfemoral access is not an option. The procedure was linked to an overall success rate of 98.5%.
Image courtesy of the World Heart Federation. Click here to view the original X/Twitter post.
“I am proud of this award, particularly because it represents Mount Sinai’s worldwide scientific contributions and dedication to advancements in the cardiovascular field,” Fuster said.
Researchers performed a new meta-analysis of data from more than 51,000 patients. They examined a wide range of outcomes that also included AFib and all-cause mortality.
Physician compensation in the United States is up 6% compared to the previous year, according to a new report. It only increased by 3.9% in cardiology, however, suggesting the specialty is slightly behind the curve.
The cardiologist has been fasting in his office since May 11. He insists that he and his colleagues need more room to provide care for a growing patient population.
New York Valves: The Structural Heart Summit replaces the Transcatheter Valve Therapy conference CRF hosted for many years. The three-day event will include 12 late-breaking clinical trials focused on TAVR and new treatments for the mitral and tricuspid valves.